Stem Cell and Tissue Engineering Laboratory, Division of Exercise Physiology, Department of Orthopaedics, West Virginia University, Morgantown, WV 26506-9196, USA.
Tissue Eng Part A. 2011 Dec;17(23-24):3067-76. doi: 10.1089/ten.TEA.2011.0158. Epub 2011 Sep 21.
Our objective was to assess the rejuvenation effect of extracellular matrix (ECM) deposited by human bone marrow stromal cells (hBMSCs) on hBMSC expansion and tissue-specific lineage differentiation potential. Passage 5 hBMSCs were expanded on ECM or conventional plastic flasks (Plastic) for one passage. Cell number was counted and immunophenotype profiles were assessed using flow cytometry. Selected integrins and proliferation-related pathway signals were assessed using Western blot. The expanded cells were evaluated for their chondrogenic potential in a pellet culture system with TGF-β3-containing chondrogenic medium using gross morphology, histology, immunostaining, biochemical analysis, real-time polymerase chain reaction, Western blot, and biomechanical testing. ECM-expanded hBMSCs were further evaluated for their osteogenic potential using Alizarin Red S staining and alkaline phosphatase activity assay and for their adipogenic potential using Oil Red O staining. ECM-expanded hBMSCs exhibited an enhanced proliferation capacity and an acquired robust chondrogenic potential compared to those grown on Plastic. ECM expansion decreased intracellular reactive oxygen species and increased stage-specific embryonic antigen-4 expression in hBMSCs. ECM expansion also upregulated integrins α2 and β5 and induced a sustained activation of Erk1/2 and cyclin D1. Interestingly, upregulation of TGF-β receptor II during cell expansion and chondrogenic induction might be responsible for an enhanced chondrogenic potential in ECM-expanded hBMSCs. We also found that ECM-expanded hBMSCs had an increased osteogenic potential and decreased adipogenic capacity. ECM deposited by hBMSCs may be a promising approach to expand BMSCs from elderly patients for the treatment of large-scale bone defects through endochondral bone formation.
我们的目的是评估细胞外基质(ECM)沉积对骨髓基质细胞(hBMSCs)扩增和组织特异性谱系分化潜能的再生作用。第 5 代 hBMSCs 在 ECM 或传统塑料培养瓶(Plastic)上传代培养 1 代。通过流式细胞术计数细胞数量并评估免疫表型谱。使用 Western blot 评估选定的整合素和增殖相关途径信号。在含有 TGF-β3 的软骨形成培养基的微球体培养系统中,通过大体形态学、组织学、免疫染色、生化分析、实时聚合酶链反应、Western blot 和生物力学测试评估扩增细胞的软骨形成潜能。进一步用茜素红 S 染色和碱性磷酸酶活性测定评估 ECM 扩增 hBMSCs 的成骨潜能,用油红 O 染色评估其成脂潜能。与在 Plastic 上生长的细胞相比,ECM 扩增的 hBMSCs 表现出增强的增殖能力和获得的强大的软骨形成潜能。ECM 扩增降低了 hBMSCs 中的细胞内活性氧,并增加了阶段特异性胚胎抗原-4 的表达。ECM 扩增还上调了整合素α2 和β5,并诱导 Erk1/2 和细胞周期蛋白 D1 的持续激活。有趣的是,细胞扩增和软骨形成诱导过程中 TGF-β受体 II 的上调可能是 ECM 扩增 hBMSCs 增强软骨形成潜能的原因。我们还发现 ECM 扩增的 hBMSCs 具有增强的成骨潜能和降低的成脂能力。hBMSCs 沉积的 ECM 可能是一种有前途的方法,可以通过软骨内骨形成从老年患者中扩增 BMSCs,用于治疗大规模骨缺损。